Skip to content

Home
About
Business
- Pipeline
Science
Patients
Investors
- Message
- IR News
- IR Library
- IR Governance
- IR Calendar
- Stock
- FAQ
- Email Alerts
Careers
Contact
EN
- JP
- EN

IR News

Home IR News

WHAT'S NEW

Press Releases

Recent IR filings

About
Business
- Pipeline
Science
News
Patients
Investors
- Message
- Stock
- IR Governance
- IR Library
- IR Calendar
- FAQ
Careers
Contact

Message from CEO

Company History

Genome Editing: CRISPR

Science Epigenome

© Modalis Therapeutics Corporation

Home
About
Business
- Pipeline
Science
Patients
Investors
- Message
- IR News
- IR Library
- IR Governance
- IR Calendar
- Stock
- FAQ
- Email Alerts
Careers
Contact
EN
- JP
- EN